Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

294.08
Delayed Data
As of Aug 16
 +6.16 / +2.14%
Today’s Change
244.28
Today|||52-Week Range
303.81
+12.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line1.0B647.9M747.5M862.8M
 
 
 
 
 
Depreciation180.2M177.4M512.0M302.6M
 
 
 
 
 
Total Other Cash Flow47.3M94.8M55.1M85.7M
 
 
 
 
 
Funds From Operations1.2B801.9M1.4B1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses244.5M-774.7M1.2B-14.7M
 
 
 
 
 
Net Cash Flow - Operating Activities986.6M1.6B235.2M1.2B
 
 
 
 
 
 
InvestingIncrease In Investments-1.8B-2.3B-1.3B-1.3B
 
 
 
 
 
Decrease In Investments2.4B2.2B1.9B1.7B
 
 
 
 
 
Capital Expenditures-170.3M-182.1M-210.0M-197.7M
 
 
 
 
 
Other Investing - Uses-246.9M-310.0M-306.6M-300.7M
 
 
 
 
 
Net Cash Flow Investing36.2M-581.7M-744.2M-202.6M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings--0.00------
Long Term Debt Reduction--0.00------
Net Proceeds Stock Sale11.3M8.5M0.000.00
 
 
 
Common Preferred Redeemed-348.9M-651.1M-583.6M-781.8M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing39.7M-37.2M10.4M23.1M
 
 
 
 
 
Other Uses - Financing----328.2M-7.7M
 
 
 
Net Cash Flow - Financing-300.6M-721.2M-901.4M-751.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash600.0K-32.0M7.9M29.9M
 
 
 
 
 
 
Net Change In Cash722.2M273.7M-1.4B215.6M